微流体设备市场规模、份额、成长分析（按产品、材料、应用、最终用户和地区）- 2025-2032 年产业预测

预计到 2023 年全球微流体设备市场规模将达到 244.8 亿美元，从 2024 年的 276.1 亿美元成长到 2032 年的 723.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 12.8%。

全球微流体设备市场经历了显着的成长，预计未来将继续加速成长。这些创新工具对于医疗保健、製药、生物技术和研究实验室等多个领域都至关重要。这些工具可以轻鬆建立紧凑、可携式且经济高效的诊断解决方案，并提供快速、准确的结果。微流体设备将样品製备、分析和检测功能整合到单一平台，使其特别适合在偏远、资源有限的地区使用。在医疗保健领域，它透过缩小测试过程并减少所需的样本和试剂量，彻底改变了医疗诊断。因此，基于微流体的检测技术正在提高检测的速度、效率和成本效益，促进其在分子诊断、免疫测定、细胞分析和基因组学中的应用，从而显着增加市场需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 原料分析

微流体设备市场规模（依产品）

• 市场概况
• 基于微流体的设备
• 微流体元件
  • 微流体晶片
  • 流量和压力感测器
  • 流量和压力控制器
  • 微流体阀
  • 微型帮浦
  • 微型针
  • 其他组件

微流体设备市场规模（依材料）

• 市场概况
• 玻璃
• 硅
• 聚合物
• 其他的

微流体设备市场规模（依应用）

• 市场概况
• 体外诊断
  • 临床诊断
  • 就地检验
  • 兽医诊断
• 製药与生命科学研究与製造
  • 实验室分析
  • 微量点胶
  • 微反应
• 治疗
  • 药物输送
  • 穿戴式装置

微流体设备市场规模（依最终用户划分）

• 市场概况
• 製药和生物技术公司
• 研究组织
• 诊断中心
• 医疗保健设施等

微流体设备市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Bio-Rad Laboratories（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• bioMerieux（France）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Sphere Fluidics（UK）
• Standard BioTools（formerly Fluidigm Corporation）（USA）
• BD（Becton, Dickinson and Company）（USA）
• IDEX Corporation（USA）
• SMC Corporation（Japan）
• Parker Hannifin Corporation（USA）
• Fortive Corporation（USA）
• Aignep SpA（Italy）
• Lonza Group（Switzerland）
• Emulate（USA）
• Dolomite Bio（UK）

结论和建议

Global Microfluidic Devices Market size was valued at USD 24.48 billion in 2023 and is poised to grow from USD 27.61 billion in 2024 to USD 72.38 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The global microfluidic devices market is experiencing remarkable growth, projected to accelerate further. These innovative tools are essential across various sectors, including healthcare, pharmaceuticals, biotechnology, and research labs. They facilitate the creation of compact, portable, and cost-effective diagnostic solutions that provide rapid, accurate results. By integrating functions like sample preparation, analysis, and detection onto a single platform, microfluidic devices are particularly suited for resource-limited and remote settings. The healthcare sector has been a key adopter, transforming medical diagnostics through the miniaturization of laboratory processes and minimizing sample and reagent requirements. Consequently, microfluidic-based assays enhance testing speed, efficiency, and cost-effectiveness, driving their use in molecular diagnostics, immunoassays, cell analysis, and genomics, thereby significantly increasing market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Devices Market Segmental Analysis

Global Microfluidic Devices Market is segmented by Product, Material, Application, End User and region. Based on Product, the market is segmented into Microfluidic-based Devices and Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer and Others. Based on Application, the market is segmented into In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Centers and Healthcare Facilities and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is experiencing significant growth driven by the rising demand for compact and portable solutions across multiple industries such as healthcare, pharmaceuticals, and biotechnology. These devices are ideally positioned to address this need due to their small footprint, which allows for reduced sample consumption and the integration of various functions into a single device. Their capability to execute intricate laboratory procedures on a miniature scale, coupled with the convenience of portability and the ability for on-site analysis, has led to increased adoption. This trend is propelling the expansion of the microfluidic devices market as it caters to evolving application demands.

Restraints in the Global Microfluidic Devices Market

The global microfluidic devices market faces certain restraints primarily due to limited awareness and slow adoption in various industries beyond healthcare and diagnostics. Sectors such as agriculture, environmental monitoring, and food testing, which stand to benefit significantly from microfluidic technologies, tend to adopt these innovations at a slower pace. This lag is often attributed to inadequate awareness, insufficient infrastructure, and a strong reliance on traditional methods. To foster market growth, it is essential to enhance awareness and educate potential end-users about the diverse advantages and applications of microfluidic devices across these underserved industries.

Market Trends of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is witnessing a robust trend toward the increased adoption of point-of-care testing (POCT) applications, driven by the growing demand for rapid and accurate diagnostic solutions. Microfluidic technology facilitates immediate testing at or near the patient, enabling healthcare professionals to make swift decisions based on real-time data. The ability to manage small sample volumes, coupled with their portable and user-friendly design, positions these devices favorably across diverse healthcare environments such as hospitals, clinics, and even home care settings. This trend is particularly significant in emergency and critical care scenarios, underscoring the vital role of microfluidics in enhancing patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Microfluidic Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Microfluidic-based Devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Global Microfluidic Devices Market Size by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Global Microfluidic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearables Devices

Global Microfluidic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Diagnostic Centers
• Healthcare Facilities and Others

Global Microfluidic Devices Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sphere Fluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools (formerly Fluidigm Corporation) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations